Search

Your search keyword '"Ivf icsi"' showing total 574 results
Start Over Descriptor "Ivf icsi"
574 results on '"Ivf icsi"'

451. Effect of pioglitazone on tumor necrosis-alpha and interleukin-6 in follicular fluid and IVF/ICSI outcomes in infertile patients with endometriosis

Author

Sun Young Choi, S.-K. Kwon, Jun-Woo Ahn, Chung Hoon Kim, Kyoo-Hyung Lee, and Byung-Moon Kang

Subjects
biology, business.industry, Endometriosis, Obstetrics and Gynecology, Alpha (ethology), Ivf icsi, medicine.disease, Follicular fluid, Andrology, Reproductive Medicine, biology.protein, medicine, Tumor necrosis factor alpha, Interleukin 6, business, Pioglitazone, medicine.drug
Published
2012
Full Text
View/download PDF

453. P25.03: Effect of IVF/ICSI on second trimester screening markers

Author

Luisa Marrone, Francesco D'Antonio, Barbara Matarrelli, M. Recchi, Claudio Celentano, and E. Colantuono

Subjects
medicine.medical_specialty, Second trimester screening, Reproductive Medicine, Radiological and Ultrasound Technology, business.industry, Obstetrics, Obstetrics and Gynecology, Medicine, Radiology, Nuclear Medicine and imaging, General Medicine, Ivf icsi, business
Published
2012
Full Text
View/download PDF

455. Does first polar body array CGH analysis correlate with a cleavage stage embryo biopsy in IVF-ICSI cycles and preimplantation genetic screening

Author

Glenn L. Schattman, T. Singer, Kangpu Xu, A.R. Victor, Z. Rosenwaks, and C. Zhang

Subjects
Gynecology, medicine.medical_specialty, medicine.diagnostic_test, business.industry, Concordance, Obstetrics and Gynecology, Embryo, Ivf icsi, Biology, Cleavage stage embryo, Pregnancy rate, Reproductive Medicine, Biopsy, medicine, First polar body, business, SNP array
Abstract

OBJECTIVE: To correlate first polar body(PB1) biopsy(Bx) aCGH technology with cleavage stage(D3) Bx results analyzed with FISH or SNP-array. DESIGN: Prospective clinical trial. Main Outcome: Concordance between PB1 and D3 results, ongoing pregnancy rates and IVF outcome. MATERIALS AND METHODS: Between 09/11-04/12, 27 patients(Pts) consented and 15 enrolled and underwent PB1 Bx followed by a D3 Bx.11 Pts completed their cycle with a total of 101 PB1 and corresponding D3 Bxs.All mature oocytes(MII) were fertilized by ICSI 4-6h post retrieval with PB1 Bx performed and frozen 2-4h thereafter.D3 Bx was then performed and analyzed using 9 probe FISH(13,15,16,17,18,21,22,X,Y) or 24 chromosomes SNP array(physician/Pts preference).Clinical decisions were based solely on D3 analysis.ET was performed on D5. RESULTS: 83% of MIIs fertilized normally.Concordance analysis of PB1 and corresponding D3 revealed 67.3% partial/complete concordance and 32.7% discordance(6% normal embryos possibly discarded or 26.7% abnormal embryos possibly transferred).When 9-probe FISH was used partial concordance was expected.PB1 had a 82% sensitivity and 55% specificity when compared to D3.Kappa statistic was 0.35[fair agreement], P1⁄40.0001(95% CI1⁄40.14,0.54) Implantation rate was 31%(average of 2.28 fresh embryos per ET). Pregnancy rate/cycle started was 36% with 27% ongoing(57% and 42% per cycle transferred).

Published
2012
Full Text
View/download PDF

457. Reply of the Authors

Author

Ismail Aboulfoutouh, Hesham Al-Inany, Walid El-Khyat, Fulco van der Veen, Madelon van Wely, and Mohamed Abdelfattah Mahmoud Youssef

Subjects
Corifollitropin alfa, medicine.medical_specialty, Reproductive Medicine, Obstetrics, business.industry, Meta-analysis, medicine, Obstetrics and Gynecology, Ivf icsi, business
Published
2012
Full Text
View/download PDF

458. Comment on, 'Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis'

Author

P. Verweij, Bernadette Mannaerts, and Keith Gordon

Subjects
Male, Corifollitropin alfa, medicine.medical_specialty, business.industry, Obstetrics, Obstetrics and Gynecology, Fertility Agents, Female, Fertilization in Vitro, Ivf icsi, Ovulation Induction, Reproductive Medicine, Pregnancy, Infertility, Meta-analysis, Humans, Medicine, Female, Follicle Stimulating Hormone, Human, Sperm Injections, Intracytoplasmic, business
Published
2012
Full Text
View/download PDF

459. Morphological Abnormalities in 2-Year-Old Children Born After IVF/ICSI with Preimplantation Genetic Screening (PGS)

Author

R Breur, Jan Maarten Cobben, M Van Der Heide, Joke Kok, Sebastiaan Mastenbroek, J H Van Der Lee, Karin J. Middelburg, Mijna Hadders-Algra, F. Beukers, and Arend F. Bos

Subjects
musculoskeletal diseases, Gynecology, endocrine system, medicine.medical_specialty, Pregnancy, urogenital system, Obstetrics, Anthropometry, Ivf icsi, Biology, medicine.disease, law.invention, carbohydrates (lipids), Pregnancy rate, Increased risk, Randomized controlled trial, law, Pediatrics, Perinatology and Child Health, medicine, lipids (amino acids, peptides, and proteins), Advanced maternal age, Abnormality
Abstract

Background and aims: Increased risk for chromosomal abnormalities in embryos is considered as a cause of low pregnancy rate with advanced maternal age. PGS has been suggested to improve pregnancy outcome. Since PGS includes extensive embryo manipulation, PGS could have an effect on morphological outcome in children. A follow-up study of a RCT comparing IVF/ICSI with PGS (PGS+) and without (PGS-) was performed to evaluate morphological abnormalities of live born children at 2 years of age. Methods: 408 women were included in a multicenter RCT on the efficacy of PGS. There were 120 women with ≥1 live births, 119 mothers with 142 children alive (57 PGS+; 85 PGS-) were available for follow-up. A reference group of 67 children conceived naturally was formed. At 2 years of age a body-surface examination and anthropometry was performed. Morphological abnormalities were classified as major abnormalities, minor anomalies or common variants according to Merks (Am J Med Genet 2003;123A:211-230). Results: No significant association was found between PGS and any specific minor anomaly or major abnormality. The proportions [95% CI] of children with ≥1 minor anomalies and ≥1 major abnormalities for PGS+ versus PGS- were 64 % [50 -76] vs 67 % [55 - 77] and 28 % [18 - 42] vs 35 % [25 - 46], respectively. No significant differences were found between the randomized and reference groups. Conclusions: This study found no differences in morphological abnormalities between children conceived after IVF/ICSI with PGS and children conceived after regular treatment.

Published
2011
Full Text
View/download PDF

462. Comparison of IVF/ICSI outcomes in male factor infertility patients with and without spinal cord injuries

Author

Marcelo J. Barrionuevo, Nancy L. Brackett, Anupama S.Q. Kathiresan, Steven J. Ory, Charles M. Lynne, and George R. Attia

Subjects
Gynecology, medicine.medical_specialty, medicine.anatomical_structure, Reproductive Medicine, business.industry, medicine, Urology, Obstetrics and Gynecology, Ivf icsi, Male factor infertility, Spinal cord, business
Published
2011
Full Text
View/download PDF

463. A multicenter comparison of set and standard IVF/ICSI

Author

Bulent Ergun, R. Galandarov, Erkut Attar, Ercan Bastu, G. Koksal, and Harika Yumru

Subjects
Gynecology, Set (abstract data type), medicine.medical_specialty, Reproductive Medicine, business.industry, medicine, Obstetrics and Gynecology, Ivf icsi, business
Published
2011
Full Text
View/download PDF

470. Recombinant versus urinary human chorionic gonadotropin for final oocyte maturation triggering in IVF/ICSI cycles. Cochrane systematic review and meta-analysis

Author

Mohamed A. Aboulghar, Mohamed A. Youssef, Ragaa T. Mansour, M. Proctor, and Hesham Al-Inany

Subjects
Gynecology, medicine.medical_specialty, business.industry, Urinary system, Obstetrics and Gynecology, Ivf icsi, Oocyte, law.invention, Human chorionic gonadotropin, Andrology, medicine.anatomical_structure, Reproductive Medicine, law, Meta-analysis, Recombinant DNA, Medicine, business
Published
2010
Full Text
View/download PDF

472. The value of delaying hCG administration to enable maturation of medium sized follicles in patients undergoing superovulation for IVF/ICSI

Author

Anthony N. Imudia, Elizabeth E. Puscheck, Deslyn T.G. Hobson, Valerie I. Shavell, Terri L. Woodard, and Awoniyi O. Awonuga

Subjects
Gynecology, medicine.medical_specialty, Reproductive Medicine, Obstetrics, business.industry, medicine, Obstetrics and Gynecology, In patient, Ivf icsi, business, Value (mathematics)
Published
2010
Full Text
View/download PDF

485. Evaluation of the practice of delaying HCG administration to enable maturation of medium size follicles in patients undergoing superovulation for IVF/ICSI

Author

F.D. Yelian, Anthony N. Imudia, Michael P. Diamond, Awoniyi O. Awonuga, T. Wooddard, and Elizabeth E. Puscheck

Subjects
Gynecology, medicine.medical_specialty, Reproductive Medicine, business.industry, medicine, Obstetrics and Gynecology, In patient, Ivf icsi, business, Administration (government)
Published
2009
Full Text
View/download PDF

486. Effect of laser assisted hatching (LAH) on IVF/ICSI cycles in women who were thirty-eight or more years old and its relation to the thickness of the zona pellucida in the same group of patients

Author

B. Amorocho, J.J. Landeras, D. López, L. Fernández, P.P. Albero, and M.M. Nicolás

Subjects
Gynecology, medicine.medical_specialty, medicine.anatomical_structure, Reproductive Medicine, business.industry, medicine, Obstetrics and Gynecology, Ivf icsi, Zona pellucida, business, Laser assisted hatching
Published
2009
Full Text
View/download PDF

488. The experience of the surgeons affects ovarian reserve and pregnancy outcome after laparoscopic treatment of endometriosis in infertile patients with IVF/ICSI

Author

Hsing-Tse Yu, Y.-K. Soong, H.-Y. Huang, Huei-Shyong Wang, Wang Cj, and Lee Cl

Subjects
Gynecology, medicine.medical_specialty, Pregnancy, business.industry, Obstetrics, Endometriosis, Obstetrics and Gynecology, Ivf icsi, medicine.disease, Reproductive Medicine, medicine, business, Ovarian reserve, Laparoscopic treatment
Published
2009
Full Text
View/download PDF

491. OP02.11: No significant difference between nuchal translucency (NT) in weeks 11-13+6 of singleton pregnancies conceived spontaneously and by IVF/ICSI

Author

P. O'Donoghue, E. Greenblatt, I. Bromberg, Ants Toi, Barry Hoffman, K. Fong, and Nanette Okun

Subjects
medicine.medical_specialty, Radiological and Ultrasound Technology, Singleton, business.industry, Obstetrics, Significant difference, Obstetrics and Gynecology, General Medicine, Ivf icsi, Reproductive Medicine, Nuchal translucency, Medicine, Radiology, Nuclear Medicine and imaging, business
Published
2009
Full Text
View/download PDF

492. Is the level of estrogen on the day of hCG and pattern of estrogen rise during superovulation associated with adverse pregnancy outcomes in IVF/ICSI cycles?

Author

F.D. Yelian, Anthony N. Imudia, Michael P. Diamond, Elizabeth E. Puscheck, D.R. Armant, and Awoniyi O. Awonuga

Subjects
Gynecology, medicine.medical_specialty, Reproductive Medicine, Obstetrics, Estrogen, medicine.drug_class, business.industry, medicine, Obstetrics and Gynecology, Ivf icsi, Pregnancy outcomes, business
Published
2009
Full Text
View/download PDF

495. O-112. An open, randomized, group-comparative bi-centre study comparing recombinant FSH Follitropinum β 150 IU and highly purified urinary FSH 225 IU as a fixed dose regimen in IVF/ICSI treatment

Author

N. De Quay, M. Germond, P. Chabloz, S. Walton, E. Berger, Martin Birkhäuser, and A. Sann

Subjects
endocrine system, medicine.medical_specialty, business.industry, Urinary system, Rehabilitation, Urology, Obstetrics and Gynecology, 610 Medicine & health, Ivf icsi, Fixed dose, Recombinant fsh, Regimen, Reproductive Medicine, medicine, business, hormones, hormone substitutes, and hormone antagonists
Published
1999
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results